KPS Life is a stand-alone, global functional service provider (FSP) that offers a clinical outsourcing solution to the Biopharmaceutical, Medical Device and Diagnostic sectors across all phases of clinical drug development. Our services include clinical monitoring, clinical monitoring oversight, clinical trial management, data management, biometrics, and medical writing.
The KPS Life FSP model is a proven alternative to traditional staffing and full-service organisation methodologies and affords sponsors the opportunity to contract dedicated, embedded resources to complement their clinical teams while maintaining brand identity and strategic control of assets.
Operating in 50 countries across the globe, KPS Life is committed to working together with its clients through a hands-on operating model rooted in a partnership approach. KPS Life has carved out a leadership position within the FSP market sector by providing customised and scalable solutions that improve the quality and execution of clinical trials while mitigating costs and increasing transparency for its clients.
Founded in 2010 and headquartered in Malvern, Pennsylvania, KPS Life is institutionally backed by LongueVue Capital (LVC). LVC is an entrepreneur-centric private equity firm based in New Orleans with around $500m of assets under management. The company focuses on partnering with management teams through both growth and control investments across a variety of sectors, healthcare being the largest.